Jessica obtained a Bachelor of Science at the University of Sydney in 2016. She then completed her honours project at the Lambert Initiative for Cannabinoid Therapeutics in 2019, where she assessed the therapeutic potential of full-spectrum cannabis extracts in a mouse model of Dravet syndrome. Jessica is deeply passionate about deciphering molecular signatures in mental disorders underpinning deterrence from normal thought processes. Jessica joined the Schizophrenia Research Laboratory in 2020 as a PhD candidate aspiring to assess the health of dopamine neurons in the midbrain in schizophrenia.